Synedica Retatrutide 40mg Research Presentation
Synedica-branded Retatrutide 40mg pen-kit presentation. The manufacturer describes a kit containing one 40mg pen, 12 disposable needles and an instruction booklet. Peptrion Labs presents those pack details for catalogue identification only and does not reproduce the manufacturer’s dosing or human-use guidance.
Taxes included.
This catalogue item is sold out and cannot be added to cart or purchased through Peptrion Labs.
Product facts
- 40mg labelled Retatrutide content
- Synedica-branded pen-kit presentation
- Manufacturer lists 1 pen, 12 disposable needles and 1 instruction booklet
- Sold out through Peptrion Labs
Research-use notice
- Not supplied for human consumption, personal use, veterinary use, diagnosis, treatment or administration.
- No dosing or administration guidance is provided by Peptrion Labs.
Brand & source
- Synedica-branded catalogue presentation.
- Product-format information on this page is based on the manufacturer listing linked below.
PRODUCT RECORD / SYNEDICA
Research presentation overview
Retatrutide is described by Synedica as acting at GLP-1, GIP and glucagon receptors. For Peptrion Labs, this page is framed strictly around research context and product identification rather than human benefit, weight-loss, dosing or administration claims.
R&D context
The Synedica source lists stability testing, formulation development, excipient compatibility testing, protease-resistance evaluation, encapsulation/carrier-system work and in-vitro research among its R&D applications. These are manufacturer-described research contexts, not independent Peptrion Labs analytical results.
For laboratory research use only. This listing does not provide dosing, treatment, administration or clinical guidance and does not establish safety, efficacy or regulatory approval for human or veterinary use.
SOURCE REGISTER
Manufacturer product information
For the original Synedica catalogue description and presentation details, refer to the manufacturer source. Peptrion Labs' research-use restrictions on this page remain applicable to this catalogue listing.